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Abstract
Purpose/Objectives—To evaluate the process of survivorship care plan (SCP) completion and 
to survey oncology staff and primary care physicians (PCPs) regarding challenges of 
implementing SCPs.
Design—Descriptive pilot study.
Setting—Two facilities in Vermont, an urban academic medical center and a rural community 
academic cancer center.
Sample—17 oncology clinical staff created SCPs, 39 PCPs completed surveys, and 58 patients 
(breast or colorectal cancer) participated in a telephone survey.
Methods—Using Journey Forward tools, SCPs were created and presented to patients. PCPs 
received the SCP with a survey assessing its usefulness and barriers to delivery. Oncology staff 
were interviewed to assess perceived challenges and benefits of SCPs. Qualitative and quantitative 
data were used to identify challenges to the development and implementation process as well as 
patient perceptions of the SCP visit.
Dulko can be reached at dorothydulko@gmail.com. 
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Preliminary results from this study were presented during at the Sixth Biennial Cancer Survivorship Research Conference, “Cancer 
Survivorship Research: Translating Science to Care,” in Arlington, VA, from June 14–16, 2012.
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Main Research Variables—SCP, healthcare provider perception of barriers to completion and 
implementation, and patient perception of SCP visit.
Findings—Oncology staff cited the time required to obtain information for SCPs as a challenge. 
Completing SCPs 3–6 months after treatment ended was optimal. All participants felt advanced 
practice professionals should complete and review SCPs with patients. The most common 
challenge for PCPs to implement SCP recommendations was insufficient knowledge of cancer 
survivor issues. Most patients found the care plan visit very useful, particularly within six months 
of diagnosis.
Conclusions—Creation time may be a barrier to widespread SCP implementation. Cancer 
survivors find SCPs useful, but PCPs feel insufficient knowledge of cancer survivor issues is a 
barrier to providing best follow-up care. Incorporating SCPs in electronic medical records may 
facilitate patient identification, appropriate staff scheduling, and timely SCP creation.
Implications for Nursing—Oncology nurse practitioners are well positioned to create and 
deliver SCPs, transitioning patients from oncology care to a PCP in a shared-care model of 
optimal wellness. Institution support for the time needed for SCP creation and review is 
imperative for sustaining this initiative.
Knowledge Translation—Accessing complete medical records is an obstacle for completing 
SCPs. A 3–6 month window to develop and deliver SCPs may be ideal. PCPs perceive insufficient 
knowledge of cancer survivor issues as a barrier to providing appropriate follow-up care.
As of January 2012, an estimated 13.7 million cancer survivors were living in the United 
States (Siegel et al., 2012). The five-year relative survival rate in the United States for all 
cancers has improved from 49% for cases diagnosed from 1975–1979 to 67% for cases 
diagnosed in 2004 (Howlader et al., 2011). The cancer survivor population is growing 
concurrently with a projected shortage of oncology physicians (Erikson, Salsberg, Forte, 
Bruinooge, & Goldstein, 2007). With total oncology visits projected to increase from 38 
million in 2005 to 57 million in 2020, the United States is expected to face a 48% increase in 
demand for oncologist services by 2020 (Erikson et al., 2007). The rapidly increasing 
survivor population and predicted inevitable shortages of both oncology specialists and 
primary care physicians (PCPs) present a barrier to ensuring high-quality surveillance care 
for cancer survivors (Potosky et al., 2011).
Cancer survivors face several challenges, including late and long-term effects of therapy and 
uncertainty regarding follow-up care. The Institute of Medicine (IOM) recommended that 
patients with cancer and their PCP receive a written survivorship care plan (SCP) at the end 
of active treatment that communicates what occurred during cancer treatment. That 
document should include a comprehensive care summary and a plan specifically outlining 
the responsibility of each provider in follow-up care (Hewitt, Greenfield, & Stovall, 2005). 
Despite the recommendation by the IOM that an SCP is integral to achieving high-quality 
care, practical barriers exist to the creation of written documents (Earle, 2006). With 
oncology care often taking place in multiple outpatient and inpatient settings, compiling 
information can be arduous and time-consuming. Oncology providers may need to request 
multiple medical charts to document a single episode of care or a set of services required to 
manage a patient with cancer over time.
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In urban areas, a patient with cancer may have surgery at one hospital, receive radiation 
therapy at another institution, undergo chemotherapy at a private oncologist’s office, and 
return to see their PCP closer to home (National Research Council, 2007). Although those 
challenges to creating SCPs are recognized, some argue that an SCP is not unlike a hospital 
discharge summary or operative note, both of which are considered standard of care (Hewitt 
et al., 2005). Some have suggested that oncologists are unaware of cancer survivors’ desires 
for information contained in the SCP (Harrington, Hansen, Moskowitz, Todd, & Feuerstein, 
2010). Other reports indicate that the quality of cancer care is optimal when responsibility 
for care is shared by oncologists and PCPs (Salz, Oeffinger, McCabe, Layne, & Bach, 
2012).
The goal of the current pilot study was to evaluate oncology staff perceptions of and 
perceived barriers and facilitators to developing and implementing SCPs. Obstacles to the 
use of an SCP by PCPs also were assessed. Patient perceptions regarding the care plan visit 
were obtained. These results can be used to modify the future design of care plans and the 
systems that provide them to facilitate ease of transition into clinical practice.
The shared-care model provided the conceptual framework for this study (Gilbert, Miller, 
Hollenbeck, Montie, & Wei, 2008) because it underscores coordination between healthcare 
providers who practice in different specialties or locations with consideration of patient 
involvement. Knowledge transfer, channels of communication, and patient input provide the 
underlying structure for the model, underscoring the reintegration of PCPs into survivorship 
care. The role of the advanced practice professional (APP) is enmeshed within the 
multidisciplinary oncology care team. In this pilot study, an APP is defined as a nurse 
practitioner or physician assistant.
Methods
Sample
The study was conducted at two sites: Fletcher Allen Health Care, an urban academic 
medical center in Burlington, VT, and Norris Cotton Cancer Center North, a rural academic 
medical center in St. Johnsbury, VT. Eligible participants were patients with stage 0–III 
breast cancer or stage II–IV colorectal cancer, aged 18 years and older, who had completed 
treatment with intent to cure up to 12 months before or during the study time period of 
November 2010 to April 2011. A total of 89 patients were invited to participate in the study 
and 78 agreed (88%), including 61 with breast cancer and 17 with colorectal cancer. Fifty-
eight patients, including 48 with breast cancer and 10 with colorectal cancer, completed a 
telephone survey. The remaining 20 patients either refused to complete the telephone 
interview (n = 6) or could not be contacted (n = 14). Nonrespondents had similar patterns of 
cancer stage and treatment to those who completed the interview. Sixteen of 17 oncology 
staff members (94%), including oncologists, APPs, and nurses, completed a telephone 
interview at completion of the study. Fifty-five surveys were sent to PCPs, with 39 returned 
for a response rate of 71%. Patients provided written informed consent. Consent for PCPs 
and oncology staff was implied by their willingness to complete the survey or be 
interviewed. The study was approved by the institutional review boards for research with 
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human subjects at both study sites and was Health Insurance Portability and Accountability 
Act (HIPAA) compliant.
The Survivorship Care Plan
The SCPs were prepared by APPs in consultation with oncologists at each study site using 
the Survivorship Care Plan Builder software tool developed by Journey Forward (Hausman, 
Ganz, Sellers, & Rosenquist, 2011), a joint program of Wellpoint, Inc., the University of 
California Los Angeles Jonsson Comprehensive Cancer Center, the National Coalition for 
Cancer Survivorship, and Genentech. Each care plan contained the following domains: (a) a 
summary of the patient diagnosis and treatment, (b) information on recommended follow-up 
care and secondary prevention, (c) information on late effects of cancer treatments received, 
and (d) a list of national and local health promotion resources. The care plans were 
modified, if necessary, with patient input and finalized. If late or long-term side effects were 
identified during the SCP visit, appropriate specialty referral was made. The SCP was 
delivered to and discussed with patients by the APPs during a one-hour care plan visit at the 
clinic.
Sources of Information
At both clinical sites, data for the Journey Forward care plan was obtained from the patient 
chart that included records from all treating practices. The treatment summary information 
was obtained from patient paper and electronic medical records and from the chemotherapy 
ordering system. Both sites had similar distribution of records across paper and electronic 
files. National resources were drawn from Hewitt et al. (2005), the Journey Forward 
resource document (http://journeyforward.org/patients/resource-patients), and the Centers 
for Disease Control and Prevention (CDC) resource links (www.cdc.gov/cancer/
survivorship/links.htm). A local resource list was developed at each site.
Implementation
Prior to beginning data collection, meetings were held at both study sites with oncologists 
and clinic staff to review examples of SCPs and surveys. That was done to refine care plans 
and discuss the process of delivery and surveys. A Journey Forward packet was downloaded 
and given to each staff member (http://journeyforward.org/professionals/oncology-
professionals). Prior to initiating data collection, the investigators met with the entire staff of 
the oncology clinic to present the study, discuss perceived challenges to implementation, 
and share ideas for improving the study. Journey Forward training was available to the APPs 
through the Journey Forward toolkit on the Web site (http://journeyforward.org/sites/
journeyforward.org/files/oncologist-toolkit_1.pdf).
The mechanism for providing the SCPs was slightly different at each site to accommodate 
variations in practice at the respective institutions. At the time of the study, Fletcher Allen 
had established post-treatment survivor visits as standard of care and, therefore, all patients 
presenting for a first or second post-therapy visit were informed that their next follow-up 
visit would be an hour-long survivor visit in which they would receive an SCP. At the 
survivor visit, they were offered the opportunity to participate in a study to evaluate the SCP 
by the nurse practitioner or physician assistant. The patients received the SCP whether they 
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did or did not consent to participation. At Norris Cotton Cancer Center North, where 
survivor visits were not standard of care at the time of the study, patients were approached at 
the end of initial oncologic therapy and offered participation in the study by the research 
nurse. If they consented, they were scheduled for an hour-long survivor visit 1–3 months 
later. The nurse practitioner presented and discussed the SCP with cancer survivors at that 
appointment. Several days prior to the visit, patients at both sites received a telephone call to 
remind them of the upcoming appointment. Figure 1 outlines the study schema at each site. 
A research assistant who was not involved in the clinics evaluated 10 randomly selected 
Journey Forward care plans for accuracy and completeness at each clinical site.
Clinical Staff Survey and Primary Care Provider and Patient Data
The APP responsible for developing the Journey Forward care plan and for the care plan 
visit kept a log that included the amount of time to create the SCP and any problems in 
retrieving the information, as well as the amount of time spent in the care plan visit. The 
oncology providers (e.g., oncologists, APPs), staff, and administrators completed a post-
study implementation phone interview conducted by the principal investigator, who was not 
involved in the clinics, to evaluate perceived benefits and challenges of implementing the 
SCPs.
A survey was developed to evaluate PCP-perceived barriers to facilitating an SCP. 
Demographic information, including number of years in practice, was obtained. The survey 
also contained an open-ended question to elicit specific comments about the SCP. The SCP 
was mailed to the PCPs with a cover letter explaining the study, the consent form, and the 
survey with a self-addressed stamped return envelope. Two attempts to contact the PCP by 
mail were carried out. PCPs who did not return the survey within 4–8 weeks were contacted 
by an oncologist involved in the study either by e-mail or telephone at the urban site; an 
administrative staff member contacted PCPs at the rural site.
Telephone interviews were conducted with patients about two months after the care plan 
visit. As many as 15 attempts were made to contact participants, including calls at varying 
times including weekdays, week-nights, and weekends, as well as voice mails left with a 
toll-free number to return the call.
Statistical and Qualitative Analyses
All statistical analyses were conducted using SAS, version 9, statistical software. 
Descriptive statistics were determined for survey responses and demographic variables. 
Tests for interaction by cancer site and facility type were conducted using Fisher’s exact 
tests. For certain questions pertaining to the care plan in general, the complete set of 
response frequencies is described. Likert scale response options for perceived barriers PCPs 
reported that may interfere with their ability to provide follow-up care for adult cancer 
survivors were used. Lack of time, insufficient knowledge of cancer survivor issues, 
inadequate recommendations from oncology staff, poor reimbursement for service, and 
limited access to cancer survivors were dichotomized as “very significant barrier” 
or ”moderate barrier” and “hardly a barrier” or “not a barrier.” The response “other,” with an 
option to write in perceived barriers, was a separate response option.
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Results
The APPs who developed and delivered SCPs to patients provided data (three nurse 
practitioners and one physician assistant). All of the APPs were women and held a Master of 
Science degree; three had a Master of Science in Nursing. Two nurse practitioners also had 
AOCNP® certification.
The mean care plan preparation time was 53.9 minutes. The most frequently reported barrier 
to completion of SCPs by APPs was the time required to read through medical records, 
particularly for patients who received care in multiple settings. Obtaining prior or outside 
records, including chemotherapy records, also was reported as an obstacle to creating SCPs. 
Consensus did not exist among the APPs as to whether the diagnosis of a new primary 
cancer should trigger the creation of a new and distinct care plan. As a result, dual cancer 
diagnoses were cited as a barrier to ease of completion of the SCP.
The majority (83%, n = 10) of clinical staff (oncologists, APPs, and RNs) reported that the 
optimal time to complete the care plan visit was 3–6 months after definitive treatment. Most 
clinical staff felt that an SCP should be provided to all patients with cancer; one APP felt 
that the SCP should only be given to patients treated with curative intent. All medical 
oncologists, APPs, and RNs interviewed felt that the APP should be responsible for 
completing and reviewing the SCP with patients. Two medical oncologists and one APP 
responded that the SCP should be completed by the APP and felt that either the APP or the 
oncologist could review the SCP with the patient during an office visit. Although 
administrative and scheduling staff reported no problems in scheduling SCP visits, it was 
suggested by a medical oncologist that a notification in the electronic medical record 
flagging the need to schedule a date for the SCP at the end of adjuvant therapy would 
facilitate compliance. When asked about the process for updating SCPs for progression of 
disease or new primary, mixed responses were received. More than half of the clinicians 
(oncologist, APPs, RNs) thought the SCP should be updated at the time of diagnosed 
progression of disease.
Sixty-four percent of PCPs surveyed cited limited access to survivors as a barrier to 
providing follow-up survivorship care. Insufficient knowledge of cancer survivor issues was 
reported as an obstacle by 58% of PCPs, followed by inadequate recommendations from 
oncology, as reported by 49% of PCPs. Other challenges reported by PCPs included lack of 
established survivor care guidelines (47%) and lack of time (45%). Poor reimbursement for 
services was reported as a barrier by 18% of PCPs. No statistically significant differences 
were reported in barriers by practice site. Some variation existed by years in practice, with 
79% of PCPs with 18 years or less in practice reporting insufficient knowledge as a barrier, 
whereas only 37% of those with more than 18 years in practice reporting it as such (p = 0.02 
for interaction).
The median age of patient respondents was 54 years (range = 35–75) for patients with breast 
cancer and 59 years (range = 41–70) for patients with colorectal cancer. The mean duration 
of the care plan visit was 59.7 minutes. All patients surveyed (N = 58) replied that the care 
plan visit provided adequate time. Only 30% of patients responded “yes” when asked if they 
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knew what to expect during the care plan visit. The majority of patients (43%) stated they 
didn’t know what to expect, and 28% reported being “unsure” of what the appointment 
would entail. When asked what was different from what they anticipated, a variety of 
responses were given. More than half of patients replied that they simply did not know what 
to expect of the visit. Twelve percent reported that the appointment was more detailed than 
they expected; those respondents perceived this as positive. One patient replied that it would 
have been useful to have the SCP review prior to the visit; another did not expect to get a 
written packet of information specific to them. Despite not having expectations of the care 
plan appointment, the majority of respondents reported finding the care plan visit useful, 
with 83% of patents stating that the visit was “very useful” and 15% reporting the visit to be 
“somewhat useful.”
In response to the question, “During the visit, how much did [name of the APP] check to 
make sure you understood everything,” the majority of patients replied “all the time” (40%), 
“very much” (22%), or “quite a bit” (31%). When asked “Was the care plan given to you at 
a time for you to best use the information provided or would a different time have been 
better,” the responses were equally divided, with 48% of patients agreeing that the SCP was 
given to them at an optimal time and 50% responding that another time would have been 
better; 2% of participants did not respond to this question. Among patients who had their 
SCP visit within six months of diagnosis, 64% agreed that the care plan was given to them at 
the right time. For patients seen at 7–12 months after diagnosis, 55% agreed. Only 29% of 
patients having an SCP visit more than 12 months after cancer diagnosis replied that the 
timing of the appointment was favorable. Of those who didn’t agree (replied “no”) that the 
SCP visit was optimally scheduled, the most frequent response as to a better time was 
“before treatment ends” (31%).
Discussion
Data from the APPs in this pilot study indicate that accessing complete medical records, 
including information regarding prior oncology treatment received at different facilities, is 
an obstacle to completing SCPs. Initiating a summary report at the start of treatment and 
updating the SCP with changes, such as late effects, progression of disease, or recurrence, in 
real time may streamline completion of the SCP and decrease the burden of time needed to 
complete the entire document at the end of treatment. Standardized templates within 
electronic medical records should be designed to automatically populate the SCP with 
pertinent clinical data in real time during treatment. That would reduce the provider time 
needed to complete the SCP at the end of treatment. Additional research is needed to 
standardize the approach to development of SCPs in patients with more than one cancer 
diagnosis to determine if multiple SCPs are necessary.
According to data from this study, oncology providers felt that 3–6 months after completion 
of definitive treatment is the optimal time for patients to receive the SCP. The timing was 
best for those patients surveyed who received the SCP during a care plan visit within six 
months after diagnosis. Additional research is needed to establish a time frame for 
developing and delivering SCPs that is feasible for providers and most valuable to survivors, 
but this study suggests that the 3–6 month window may be a promising starting point.
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The findings of the study reinforce those of Potosky et al. (2011), who found that PCPs 
perceive insufficient knowledge of cancer survivor issues as a barrier to providing 
appropriate follow-up care. Providing details within the SCP regarding late and long-term 
effects and standard monitoring tests may enhance the usefulness of SCPs. Increased 
communication between oncologists, survivors, and other healthcare providers through an 
SCP not only regarding what has been done, but also what needs to be done in the future, 
may help to more clearly delineate and facilitate the role of PCPs in survivorship care.
Although working with electronic medical record vendors may facilitate implementation, 
more research is necessary to examine whether creating an SCP can be efficient. Electronic 
medical records may facilitate identification of patients and aid in the creation of care plans 
and appropriate scheduling of patients by support staff when patients are cared for within a 
single system. For patients who receive care in multiple settings without shared information 
systems, obtaining information integral to the SCP remains a challenge. Although 
reimbursement was not reported as a major obstacle to completion or delivery of an SCP in 
this study, linking receipts of SCPs to reimbursement also may increase their use.
Limitations
The study’s findings have several limitations. The small sample size may impact the 
generalizability. Because this was a one-year pilot study with limited funding, the authors 
were only able to measure very short-term outcomes. Despite including rural and urban 
settings, the study was conducted in a geographically localized area in Vermont. The size of 
the study and lack of racial and ethnic diversity also limit the generalizability of the results.
Implications for Nursing
Nurse practitioners in oncology settings are well positioned to create and deliver SCPs, 
transitioning patients from their oncology care provider to their community PCP in a shared-
care model of achieving optimal wellness. Institutional support for the time needed to 
prepare the SCP and review the document with patients is imperative for sustaining such an 
initiative.
Advocacy organizations have promoted the concept of SCPs; however, oncology nurses 
providing education to increase patient knowledge and understanding of an SCP may be a 
strong motivator for establishing SCPs as standard of care. Nursing informatics specialists 
working with electronic medical records vendors have an opportunity to create an 
infrastructure that eases development and implementation.
Conclusions
Treatment communication and coordination may be facilitated with SCP for survivors, but 
more research is needed to examine exactly how the SCP can serve to improve coordination 
of care between PCPs and oncologists and to further establish the unique role of nurse 
practitioners in survivorship care. Additional study also is needed to determine the optimal 
method for the clinical delivery of SCPs and to validate their importance.
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Figure 1. 
Flow Diagram of Implementation Process at Both Clinical Sites
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